| 000 | 01058 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518022935.0 | ||
| 264 | 0 | _c20190813 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1365-2516 | ||
| 024 | 7 |
_a10.1111/hae.13670 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAledort, Louis M | |
| 245 | 0 | 0 |
_aThe ongoing imperative for immune tolerance induction in inhibitor management. _h[electronic resource] |
| 260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _c03 2019 |
||
| 300 |
_a183-186 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Bispecific _xpharmacology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacology |
| 650 | 0 | 4 |
_aFactor VIII _ximmunology |
| 650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTreatment Failure |
| 773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 25 _gno. 2 _gp. 183-186 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/hae.13670 _zAvailable from publisher's website |
| 999 |
_c29356735 _d29356735 |
||